Geungang Ginseng (Panax ginseng)

Geungang Ginseng is a cultivated variety of Panax ginseng containing ginsenosides—particularly Rb1, Rg1, and Re—which modulate the hypothalamic-pituitary-adrenal (HPA) axis to support stress adaptation. As a traditional Korean adaptogen, it shares the core pharmacological profile of Panax ginseng but lacks cultivar-specific clinical trial data.

Origin & History

Geungang Ginseng is a specific cultivar variant of Panax ginseng, a perennial herbaceous plant native to East Asia, primarily cultivated in Korea. The plant grows 30-60 cm tall with palmately compound leaves, and roots are harvested after 4-6 years of growth, then processed by drying and steaming (for red ginseng) or simply drying (white ginseng).

Historical & Cultural Context

Panax ginseng, including Korean cultivars like Geungang, has been used in Traditional Korean Medicine and Traditional Chinese Medicine for over 2,000 years as an adaptogen to boost vitality, improve resilience to stress, and treat fatigue. Korean cultivars were developed from local landraces to enhance root yield and quality for red ginseng production.

Health Benefits

• No specific health benefits documented - No clinical trials found for Geungang cultivar
• Traditional adaptogenic use - Used in Traditional Korean Medicine for over 2,000 years (historical evidence only)
• Potential stress resilience support - Traditional use suggests benefits for stress adaptation (no clinical evidence)
• Possible fatigue reduction - Historically used to treat fatigue in traditional medicine (no modern studies)
• May support vitality - Traditional applications for boosting vitality (no scientific validation)

How It Works

Ginsenosides in Geungang Ginseng, such as Rb1 and Rg1, interact with glucocorticoid receptors and modulate cortisol secretion by dampening HPA axis hyperactivation under stress. Rg1 has been shown to upregulate nitric oxide synthase (eNOS) activity and influence dopaminergic and serotonergic neurotransmission, contributing to its adaptogenic and neuroprotective effects. Additionally, ginsenoside Rb1 inhibits pro-inflammatory cytokines including TNF-α and IL-6 via NF-κB pathway suppression, which may underlie its anti-fatigue properties.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were found specifically for the Geungang Ginseng cultivar. The research dossier indicates that while general Panax ginseng has been studied, no PubMed PMIDs or cultivar-specific trials are available for Geungang.

Clinical Summary

No clinical trials have been conducted specifically on the Geungang cultivar of Panax ginseng; available evidence is extrapolated from broader Panax ginseng research. Randomized controlled trials on standardized Panax ginseng extracts (e.g., KRG, 200–400 mg/day) involving sample sizes of 30–100 participants have demonstrated modest improvements in cognitive performance, fatigue reduction, and immune markers. A 2013 meta-analysis of 10 RCTs found statistically significant but small-magnitude benefits for mental performance, with heterogeneous methodologies limiting generalizability. Direct claims about Geungang-specific outcomes should be considered traditional rather than evidence-based until cultivar-specific studies are conducted.

Nutritional Profile

Geungang Ginseng (Panax ginseng) is a root herb with limited macronutrient contribution at typical serving sizes. Dried root composition (per 100g dry weight): Carbohydrates ~60-70g (primarily polysaccharides and ginsan), Protein ~12-16g (including arginine, lysine, threonine-rich peptides), Fat ~1-2g, Fiber ~10-15g (including pectin and hemicellulose). Key bioactive compounds: Ginsenosides (total saponins) ~2-3% dry weight in standard Panax ginseng — primary triterpene saponins including Rb1, Rb2, Rc, Rd (protopanaxadiol group) and Rg1, Re, Rf (protopanaxatriol group); Geungang cultivar-specific ginsenoside concentration data is not independently published, but is expected to fall within standard Korean red ginseng ranges of 1.5-4% total ginsenosides. Polyacetylenes (panaxynol, panaxydol): ~0.05-0.1% dry weight. Polysaccharides (ginsan, acidic polysaccharides): ~10-20% dry weight — bioavailability moderate, enhanced by hot water extraction. Phenolic compounds: ~0.5-1.5mg GAE/g dry weight including vanillic acid, p-coumaric acid, ferulic acid. Minerals: Potassium ~400-500mg/100g, Calcium ~60-80mg/100g, Iron ~3-5mg/100g, Magnesium ~20-30mg/100g, Zinc ~1-2mg/100g, Manganese ~1.5-2.5mg/100g. Vitamins: B vitamins present in trace amounts — Niacin (B3) ~1-2mg/100g, Pantothenic acid (B5) ~0.5-1mg/100g; Vitamin C ~1-3mg/100g (largely degraded in dried/processed forms. Bioavailability notes: Ginsenoside bioavailability is inherently low (~18-30% oral absorption); gut microbiota convert major ginsenosides (Rb1, Rc) to more bioavailable metabolites compound K and protopanaxadiol, improving effective absorption. Steam processing (as in red ginseng) increases rare ginsenoside fractions (Rg2, Rg3, Rh1, Rh2) by up to 2-3 fold. Fat-soluble ginsenosides benefit from co-ingestion with lipids. No Geungang cultivar-specific nutritional data has been independently published; values reflect Panax ginseng species norms.

Preparation & Dosage

No clinically studied dosage ranges are reported for Geungang Ginseng in any form (extract, powder, or standardized). Standardization details, such as ginsenoside content, are not specified for clinical contexts. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other ginseng cultivars, rhodiola, ashwagandha, eleuthero, schisandra

Safety & Interactions

Panax ginseng, including cultivars like Geungang, is generally well tolerated at doses of 200–400 mg standardized extract daily, with the most commonly reported side effects being insomnia, headache, and gastrointestinal discomfort. It carries a clinically significant interaction with warfarin by potentially inhibiting CYP2C9-mediated metabolism, increasing bleeding risk, and should be avoided in patients on anticoagulant therapy. Ginseng may exert mild hypoglycemic effects and can potentiate insulin or oral antidiabetic agents, requiring blood glucose monitoring. Use during pregnancy and breastfeeding is not recommended due to insufficient safety data and animal studies suggesting potential teratogenic effects of ginsenoside Rb1 at high doses.